Market Research Logo

US Market Report for Stenting and Dilation Devices 2017 - MedCore

US Market Report for Stenting and Dilation Devices 2017 - MedCore

The U.S. market for stenting and dilation is defined in this report as esophageal stents and dilation balloons, duodenal stents and dilation balloons and colonic stents and dilation balloons. This research outlines the average selling prices, market values, and units sold from between 2013 and 2023 with compound annual growth rates (CAGR). It also goes into detail on the competitive landscape, providing market shares and a qualitative analysis on the leading competitors. Competitors in this market include GE Healthcare, Vital Images, Philips, Siemens, Viatronix and more.


EXECUTIVE SUMMARY
U.S. GASTROINTESTINAL ENDOSCOPIC DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
1.1 KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 GASTROINTESTINAL DISEASE: TREATMENT AND DIAGNOSTICS
2.2.1 Gastro-Esophageal Reflux Disease (GERD)
2.2.2 Barrett's Esophagus
2.2.3 Digestive Cancer
2.2.4 Gastrointestinal bleeding
2.2.5 Bile Duct Disorders
2.2.6 Crohn’s disease
2.2.7 Ulcer
2.2.8 Ogilvie Syndrome or Intestinal Pseudo-Obstruction
2.3 PATIENT DEMOGRAPHICS
2.3.11 Patient Demographics
2.3.11.1 All Digestive Diseases
2.3.11.2 Abdominal Wall Hernia
2.3.11.3 Chronic Constipation
2.3.11.4 Diverticular Disease
2.3.11.5 Prescriptions
2.3.11.6 Gastroesophageal Reflux Disease
2.3.11.7 Gastrointestinal Infections
2.3.11.8 Hemorrhoids
2.3.11.9 Inflammatory Bowel Disease
2.3.11.10 Liver Disease
2.3.11.11 Pancreatitis
2.3.11.12 Peptic Ulcer Diseases
2.3.12 Digestive Cancer
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Stenting and Dilation devices
3.1.1.1 Introduction
3.1.1.1.1 Product Matrix for Stenting and Dilation Device Market
3.2 REGULATORY ISSUES AND RECALLS
3.2.1 Stenting and Dilation device
3.3 CLINICAL TRIALS
3.3.1 Stenting and Dilation Device
3.4 PRODUCT PIPELINES
3.4.1 Boston Scientific
3.4.1.1 AXIOS™ Stent and Electrocautery Enhanced Delivery System
3.4.1.2 Acquire™ Endoscopic Ultrasound Fine Needle Biopsy (FNB) Device
3.4.1.3 Safe Enteral Feeding Product
3.4.1.4 Rotatable Snare
3.4.2 Cook Inc.
3.4.2.1 Lehman Manometry Catheter
3.4.3 Olympus
3.4.3.1 Olympus EZ Shot 3 Plus - a single-use aspiration needle
3.4.3.2 Olympus ESG-200 Electrosurgical Generator
3.4.3.3 Retooled GI Benchmarking Service
3.4.3.4 Big Screen Surgery In 4K: VISERA 4K UHD System
3.4.3.5 TJF-Q180V Duodenoscope
3.4.3.6 From AR 2015 – new strategy plan for General Surgery Unit
3.4.4 Medtronic / Covidien
3.4.4.1 Safe Enteral Feeding Product line 2016
3.4.4.2 Barrx 360 Express RFA balloon catheter for Barrett's Esophagus
3.4.5 Avantis Medical Systems
3.4.5.1 Third Eye Panoramic Colonoscopy Device
3.4.6 Pentax Medical/ HOYA
3.4.6.1 H OPTIVISTA-EPK-i7010 Video Processor for endoscopy
3.4.7 Fujifilm
3.4.7.1 Sonart SU-1 Endoscopic Ultrasonic Processors
3.4.7.2 Double Balloon Endoscope (EN-580T)
3.4.8 US Endoscopy
Moray3.4.8.1 ® micro forceps
3.4.9 CONMED Corporation
3.4.9.1 ABC D-Flex Probes
3.4.10 EndoChoice
3.4.10.1 FDA clearance for Orca™ Sterile, Single-Use Air/Water and Suction Valves
3.4.10.2 Third generation Fuse® Full Spectrum Endoscopy® System
3.4.10.3 RescueNet™ retrieval device
3.4.10.4 Lumos™ Adaptive Matrix Imaging System
3.4.11 Endogastric Solution
3.4.11.1 Next-generation version of EsophyX® Device - EsophyX® Z
3.4.12 Mederi Therapeutics
3.4.12.1 Stretta RFT3 Technology
3.4.13 C2 Therapeutics
3.4.13.1 Coldplay III Trial Validating the C2 CryoBalloon™ Focal Ablation System for treating Barret’s
Esophagus
3.4.14 Medigus
3.4.14.1 Next generation MUSE™ System for the long-term treatment of GERD
3.4.15 Merit Medical Systems, Inc.
3.4.15.1 Corvocet Biopsy System
3.4.16 Medivators, Inc.
3.4.16.1 AmplifEYE™ endoscopic overtube
3.4.17 Fujifilm Medical Systems USA, Inc.
3.4.17.1 Fujifilm Diathermic Slitter (flushknife) and Fujifilm Diathermic Slitter (clutchcutter)
3.4.17.2 New additions for Double Balloon Endoscopy (DBE) platform and the Advanced Endoscopic
Platform including FlushKnife and ClutchCutter
3.4.18 Cook Medical
3.4.18.1 New study “A Multicenter Trial, Comparing a 25G EUS Fine Needle Aspiration (FNA) Device
With a 20G EUS ProCore Fine Needle Biopsy (FNB) Device (ASPRO)”
3.4.19 Vital Images, Inc.
3.4.19.1 Vitrea CT Colon Analysis
STENTING AND DILATION DEVICE MARKET
4.1 MARKET OVERVIEW
4.2 MARKET ANALYSIS AND FORECAST
4.2.1 Total Esophageal Stent Market
Esophageal Covered-4.2.1.1 Metal Stent Market
4.2.1.2 Esophageal Bare-Metal Stent Market
4.2.1.3 Esophageal Plastic Stent Market
4.2.2 Duodenal Stent Market
4.2.3 Colonic Stent Market
4.2.4 Total Esophageal Dilation Balloon Market
4.2.4.1 Multi-Stage Esophageal Dilation Balloon Market
4.2.4.2 Single-Stage Esophageal Dilation Balloon Market
4.2.5 Colonic Dilation Balloon Market
4.2.6 Duodenal Dilation Balloon Market
4.3 DRIVERS AND LIMITERS
4.3.1 Esophageal Stent Market
4.3.1.1 Market Drivers
4.3.1.2 Market Limiters
4.3.2 Duodenal Stent Market
4.3.2.1 Market Drivers
4.3.2.2 Market Limiters
4.3.3 Esophageal Dilation Balloon Market
4.3.3.1 Market Drivers
4.3.3.2 Market Limiters
4.3.4 Colonic Dilation Balloon Market
4.3.4.1 Market Drivers
4.3.5 Duodenal Dilation Balloon Market
4.3.5.1 Market Drivers
4.3.5.2 Market Limiters
4.4 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
L I S T O F F I G U R E S
Figure 1-1: Gastrointestinal Endoscopic Device Market Share Ranking by Segment, U.S., 2016 (1 of 2)
Figure 1-2: Gastrointestinal Endoscopic Device Market Share Ranking by Segment, U.S., 2016 (2 of 2)
Figure 1-3: Companies Researched in this Report, U.S., 2016
Figure 1-4: Factors Impacting the Gastrointestinal Endoscopic Device Market by Segment, U.S. (1 of 2) .. 6
Figure 1-5: Factors Impacting the Gastrointestinal Endoscopic Device Market by Segment, U.S. (2 of 2) .. 7
Figure 1-6: Recent Events in the Gastrointestinal Endoscopic Device Market, U.S., 2012 – 2016
Figure 1-7: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016
Figure 1-8: Procedure Codes Investigated, U.S., 2016
Figure 1-9: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (1 of 4)
Figure 1-10: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (2 of 4)
Figure 1-11: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (3 of 4)
Figure 1-12: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (4 of 4)
Figure 1-13: Key Report Updates
Figure 1-14: Version History
Figure 2-1: Leading Physician Diagnoses for GI Disorders, U.S., 2009
Figure 2-2: General Statistic of Digestive Diseases: All Digestive Diseases, U.S., 2004 – 2010 (1 of 2)
Figure 2-3: General Statistic of Digestive Diseases: All Digestive Diseases, U.S., 2004 – 2010 (2 of 2)
Figure 2-4: Digestive Cancer Statistics by Type and Gender, U.S., 2016
Figure 3-1: Core Companies, Stenting and Dilation Market, U.S., 2016
Figure 3-2: Class 2 Device Recall Xlumenia NAVIX Access Device
Figure 3-3: Class 2 Device Recall Boston Scientific Rigiflex Single-Use Achalasia Balloon Dilator
Figure 3-4: Class 2 Device Recall Idev Technologies, Inc. (Abbot Vascular)
Figure 3-5: Class 2 Device Recall Cordis Corporation
Figure 3-6: Stenting and Dilation – Evaluation of the New Procedure of Gastro Duodenal Anastomos using NOTES
Figure 3-7: Stenting and Dilation – Newly Designed Covered Stent and Uncovered Stent for Malignant Colorectal Obstruction
Figure 3-8: Stenting and Dilation – Covered Versus Uncovered Self-expandable Metallic Stents
Figure 3-9: Stenting and Dilation – WallFlex™ Esophageal Fully Covered Metal Stents in Caustic Strictures Study
Figure 3-10: Stenting and Dilation – Comparison of FCSEMS and Plastic Stents (WON-MVP)
Figure 3-11: Stenting and Dilation – Removal of the Evolution® Esophageal Stent - Fully Covered
Figure 3-12: Stenting and Dilation – WallFlex Esophageal Fully Covered (FC) Benign Anastomotic Stricture
Figure 3-13: Stenting and Dilation – EndoMAXX EVT Compared to EndoMAXX
Figure 3-14: Stenting and Dilation – Covered Metallic Stent and Benign Colonic Strictures
Figure 4-1: Stenting and Dilation Market by Segment, U.S., 2013 – 2023 (US$M) (1 of 2)
Figure 4-2: Stenting and Dilation Market by Segment, U.S., 2013 – 2023 (US$M) (2 of 2)
Figure 4-3: Total Esophageal Stent Market, U.S., 2013 – 2023
Figure 4-4: Esophageal Covered-Metal Stent Market, U.S., 2013 – 2023
Figure 4-5: Esophageal Bare-Metal Stent Market, U.S., 2013 – 2023
Figure 4-6: Esophageal Plastic Stent Market, U.S., 2013 – 2023
Figure 4-7: Duodenal Stent Market, U.S., 2013 – 2023
Figure 4-8: Colonic Stent Market, U.S., 2013 – 2023
Figure 4-9: Total Esophageal Dilation Balloon Market, U.S., 2013 – 2023
Figure 4-10: Multi-Stage Esophageal Dilation Balloon Market, U.S., 2013 – 2023
Figure 4-11: Single-Stage Esophageal Dilation Balloon Market, U.S., 2013 – 2023
Figure 4-12: Colonic Dilation Balloon Market, U.S., 2013 – 2023
Figure 4-13: Duodenal Dilation Balloon Market, U.S., 2013 – 2023
Figure 4-14: Drivers and Limiters, Esophageal Stent Market, U.S., 2016
Figure 4-15: Drivers and Limiters, Duodenal Stent Market, U.S., 2016
Figure 4-16: Drivers and Limiters, Esophageal Dilation Balloon Market, U.S., 2016
Figure 4-17: Drivers and Limiters, Colonic Dilation Balloon Market, U.S., 2016
Figure 4-18: Drivers and Limiters, Duodenal Dilation Balloon Market, U.S., 2016
Figure 4-19: Leading Competitors, Esophageal Stent Device Market, U.S., 2016
Figure 4-20: Leading Competitors, Stenting and Dilation Device Market, U.S., 2016
L I S T O F C H A R T S
Chart 1-1: Gastrointestinal Endoscopic Device Market by Segment, U.S., 2013 – 2023
Chart 1-2: Gastrointestinal Endoscopic Device Market Overview, U.S., 2016 & 2023
Chart 2-1: Male Incidence, Digestive Cancer, U.S., 2016
Chart 2-2: Male Deaths, Digestive Cancer, U.S., 2016
Chart 2-3: Female Incidence, Digestive Cancer, U.S., 2016
Chart 2-4: Female Deaths, Digestive Cancer, U.S., 2016
Chart 4-1: Stenting and Dilation Market by Segment, U.S., 2013 – 2023
Chart 4-2: Stenting and Dilation Breakdown, U.S., 2016
Chart 4-3: Stenting and Dilation Breakdown, U.S., 2023
Chart 4-4: Total Esophageal Stent Market, U.S., 2013 – 2023
Chart 4-5: Esophageal Covered-Metal Stent Market, U.S., 2013 – 2023
Chart 4-6: Esophageal Bare-Metal Stent Market, U.S., 2013 – 2023
Chart 4-7: Esophageal Plastic Stent Market, U.S., 2013 – 2023
Chart 4-8: Duodenal Stent Market, U.S., 2013 – 2023
Chart 4-9: Colonic Stent Market, U.S., 2013 – 2023
Chart 4-10: Total Esophageal Dilation Balloon Market, U.S., 2013 – 2023
Chart 4-11: Multi-Stage Esophageal Dilation Balloon Market, U.S., 2013 – 2023
Chart 4-12: Single-Stage Esophageal Dilation Balloon Market, U.S., 2013 – 2023
Chart 4-13: Colonic Dilation Balloon Market, U.S., 2013 – 2023
Chart 4-14: Duodenal Dilation Balloon Market, U.S., 2013 – 2023
Chart 4-15: Leading Competitors, Stenting and Dilation Device Market, U.S., 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report